Application no. and date | 20823121.7 (espacenet) (Federated) (European Patent Register), 20200615 | Patent/reg. no. and date | DK/EP 3982956, 20240612 | Publication date | 20220420 | Priority no. and date | US 201962861855 P, 20190614, US 201916504723, 20190708, US 201916565242, 20190909 | EP pub. no. and date |
EP 3982956 20220420 | Effective date | | Applicant/owner | Atiba, Joshua O., C/o SoCal IP Law Group LLP 310 N. Westlake Blvd., Suite 120
Westlake Village, California 91362, US | Applicant ref. no. | P84912DK01 | Inventor | Atiba, Joshua O., C/o SoCal IP Law Group LLP 310 N. Westlake Blvd., Suite 120
Westlake Village, California 91362, US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/40 (2006.01) , A61K 31/436 (2006.01) , A61K 31/65 (2006.01) , A61P 25/28 (2006.01) , A61P 31/04 (2006.01) , A61P 37/06 (2006.01) | Title | TREDOBBELT FARMACEUTISK SAMMENSÆTNING TIL PROTEINHOLDIG INFEKTION | Int. application no. | US2020037787 | Int. publication no. | WO2020252475 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|